Grantham, Mayo, Van Otterloo & Co (GMO)’s Genesco GCO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GCO Stock Details GCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,900	Closed	-$243K	–	523
2023 Q4	$243K	Hold	6,900	–	–	﹤0.01%	455
2023 Q3	$213K	Sell	6,900 -31,855	-82%	-$904K	﹤0.01%	550
2023 Q2	$970K	Sell	38,755 -500	-1%	-$14.5K	﹤0.01%	499
2023 Q1	$1.45M	Sell	39,255 -10,800	-22%	-$473K	0.01%	450
2022 Q4	$2.3M	Sell	50,055 -7,500	-13%	-$340K	0.01%	416
2022 Q3	$2.26M	Sell	57,555 -40,045	-41%	-$2.14M	0.01%	407
2022 Q2	$4.87M	Buy	97,600 +3,400	+4%	+$204K	0.03%	345
2022 Q1	$5.99M	Sell	94,200 -900	-0.9%	-$58.6K	0.03%	334
2021 Q4	$6.1M	Hold	95,100	–	–	0.03%	311
2021 Q3	$5.49M	Hold	95,100	–	–	0.03%	318
2021 Q2	$6.06M	Sell	95,100 -6,600	-6%	-$358K	0.03%	308
2021 Q1	$4.83M	Sell	101,700 -500	-0.5%	-$21.5K	0.03%	327
2020 Q4	$3.08M	Sell	102,200 -39,100	-28%	-$999K	0.02%	372
2020 Q3	$3.04M	Buy	141,300 +33,400	+31%	+$654K	0.02%	332
2020 Q2	$2.34M	Buy	107,900 +84,000	+351%	+$1.55M	0.02%	383
2020 Q1	$319K	Buy	+23,900	New	+$806K	﹤0.01%	652

Other funds holding GCO

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GCO Position: Q1 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Genesco (GCO) in Q1 2024, closing a stake of 6,900 shares — an estimated $243K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GCO in Q1 2020 and held it in 16 quarters. The position peaked at $6.1M in Q4 2021. 118 funds tracked by Wall St. Rank hold GCO as of Q1 2024.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Genesco position as of Q1 2024 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 6,900 Genesco shares in Q1 2024, an estimated $243K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Genesco in Q1 2020 and held it in 16 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Genesco position peaked at $6.1M in Q4 2021.
118 funds tracked by Wall St. Rank held Genesco as of Q1 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2024, filed 14 May 2024.